Biopharmaceutical implications of compaction and consolidation in the design of drug dosage forms
Rees, J.E.
Bollettino Chimico Farmaceutico 117(7): 375-390
1978
ISSN/ISBN: 0006-6648 PMID: 743383 Document Number: 133055
Document emailed within 1 workday
Related Documents
Brock, M.H.; Dansereau, R.J.; Patel, V.S. 1994: Use of in vitro and in vivo data in the design, development, and quality control of sustained-release decongestant dosage forms PharmacoTherapy 14(4): 430-437Wang, J.; Yan, S.-C.; Yu, L.; Zhang, Y.-N. 2014: Evaluation of ecosystem service value and strategies for ecological design in land consolidation: a case of land consolidation project in Da'an City, Jilin Province, China Ying Yong Sheng Tai Xue Bao 25(4): 1093-1099
Horwitz, W.; Albert, R.H. 1985: Performance characteristics of methods of analysis used for regulatory purposes. I. Drug dosage forms. D. High pressure liquid chromatographic methods Journal - Association of Official Analytical Chemists 68(2): 191-198
Ye, Y.-m.; Wu, C.-f.; Yu, J. 2011: Ecological design of ditches in agricultural land consolidation: a review Ying Yong Sheng Tai Xue Bao 22(7): 1931-1938
Willems, P.; Sørensen, E.W.; Hansen, T.S.; Byg, R. 1988: Drugs--dosage forms Sygeplejersken 88(31): 4-7
Aronsohn, A.; Brazeau, G.; Hughes, J. 1999: The impact of space travel on dosage form design and use Journal of Gravitational Physiology: a Journal of the International Society for Gravitational Physiology 6(1): P169-P172
Helliwell, M.; Taylor, D. 1993: Solid oral dosage forms Professional Nurse 8(5): 313-317
Feldmann, E.G. 1986: Modified-release dosage forms American Journal of Hospital Pharmacy 43(10): 2565-2566
Ritschel, W.A. 1973: Bioavailability of peroral dosage forms Bollettino Chimico Farmaceutico 112(3): 137-162
Zecca, L.; Ferrario, P.; Pirola, R.; Reina, L.; Zambotti, F.; Zonta, N.; Lepore, A.M.; Scaglione, F.; Fraschini, F. 1989: Pharmacokinetics of buflomedil after various dosage forms Arzneimittel-Forschung 39(4): 518-519
Sobiczewska, M.; Borkowski, B. 1970: Determination of ajmaline in dosage forms Die Pharmazie 25(5): 334-335
DeVane, C.L.; Gill, H.S. 1997: Clinical pharmacokinetics of fluvoxamine: applications to dosage regimen design Journal of Clinical Psychiatry 58(Suppl): 7-14
Gladtke, E. 1981: Current problems in drug therapy in children. Drug interactions, age-dependent changes in pharmacokinetic data, recommendations for dosage Die Medizinische Welt 32(7): 219-224
Cid, E.; Morán, I.; Rodríguez, A.; Monaris, M.; Vidal, V. 1982: Evaluation of the absorption of various primidone dosage forms in man Therapie 37(5): 567-571
Koget, T.O. 1970: Quantitative determination of quercetin in some dosage forms Farmatsevtychnyi Zhurnal 25(3): 79-81
Zivanov-Stakić, D.; Agbaba, D.; Vladimirov, S.; Cirić, L.J. 1992: Spectrophotometric determination of diltiazem in dosage forms Farmaco 47(3): 393-396
Voigt, R.; Bornschein, M.; Grohmann, A. 1982: Storage stability of rectal dosage forms Die Pharmazie 37(7): 529-536
Lintz, W.; Hirsch, I.; Osterloh, G.; Schmidt-Böthelt, E.; Sous, H. 1984: Bioavailability of penicillin V in aqueous dosage forms Arzneimittel-Forschung 34(1): 66-71
Olivier, E.I.; Du Toit, D.; Hamman, J.H. 2007: Development of an analytical method for the evaluation of N,N-dimethylformamide in dosage form design Die Pharmazie 62(10): 735-738
Jenke, D. 2010: Application of Quality by Design (QbD) Principles to Extractables/Leachables Assessment. Establishing a Design Space for Terminally Sterilized Aqueous Drug Products Stored in a Plastic Packaging System PDA Journal of Pharmaceutical Science and Technology 64(6): 527-535